Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Inflammation
Published in: Inflammation 2/2002

01-04-2002

Inflammatory Cytokines Mediate C–C (Monocyte Chemotactic Protein 1) and C–X–C (Interleukin 8) Chemokine Expression in Human Pleural Fibroblasts

Authors: Farzad Loghmani, Kamal A. Mohammed, Najmunnisa Nasreen, Robert D. Van Horn, Joyce A. Hardwick, Kerry L. Sanders, Veena B. Antony

Published in: Inflammation | Issue 2/2002

Login to get access
Metadata
Title
Inflammatory Cytokines Mediate C–C (Monocyte Chemotactic Protein 1) and C–X–C (Interleukin 8) Chemokine Expression in Human Pleural Fibroblasts
Authors
Farzad Loghmani
Kamal A. Mohammed
Najmunnisa Nasreen
Robert D. Van Horn
Joyce A. Hardwick
Kerry L. Sanders
Veena B. Antony
Publication date
01-04-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Inflammation / Issue 2/2002
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1023/A:1014884127573

Other articles of this Issue 2/2002

Inflammation 2/2002 Go to the issue

OriginalPaper

Effects of Allergina on the Treatment of Otitis Media with Effusions

OriginalPaper

Muscle Proteolysis and Weight Loss in a Neonatal Rat Model of Sepsis Syndrome

OriginalPaper

Early Vascular Permeability in Murine Experimental Peritonitis Is Comediated by Resident Peritoneal Macrophages and Mast Cells: Crucial Involvement of Macrophage-Derived Cysteinyl-Leukotrienes

OriginalPaper

Inhibition of IL-8–Mediated MAPK Activation in Human Neutrophils by β1 Integrin Ligands
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits